Blogs

Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trials

By Aesthetic Multispecialty Society posted Jun 08, 2020 06:08 AM

  
.
0 comments
0 views

Permalink